Word of the Chair
Welcome everyone to this month’s edition of Excipients Insight.
I hope that the summer break allows you enough precious time out with family and friends. From a work perspective the holiday season does however enable us to review the various events which took place during the past months in the regulatory arena and to consider their impact and value to the industry, including all the stakeholders and the patients we serve. This invaluable time also provides an insightful opportunity by which we can think of ways to further improve our cooperation with each other and all other organisations with which we work.
In this month’s edition, we have put together some useful summaries and reminders on the ongoing work in the areas of global excipient certification, the recent adoption of the falsified medicines directive, the publication of the draft guideline on pharmaceutical development of medicines for pediatric use, as well as other developments in Europe and beyond.
Last but not least, our preparations for the upcoming IPEC Europe 20th anniversary celebration are well underway. So, don't forget to mark your calendars for the event on January 27, 2012, in Barcelona, Spain.
IPEC Europe Chair